JENNIFER BROWN: Open Payments
NPI 1851768642 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 45 payments from 11 companies in 2025. Trend: 2023 $2,416 · 2024 $590 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $313 |
| Novo Nordisk Inc | 2 | $146 |
| Janssen Biotech, Inc. | 8 | $141 |
| GENZYME CORPORATION | 3 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Inari Medical, Inc. | 1 | $26 |
| Stryker Corporation | 1 | $21 |
| Janssen Scientific Affairs, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: TREMFYA, Wegovy, SKYRIZI, DUPIXENT, ENTYVIO, RINVOQ, LINZESS, CREON.
Industry payments across LA — which companies pay providers there.
